Status: Recruiting
A Phase 2/3 Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.
Participants needed: 168
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Priovant Therapeutics, Inc.Updated: Aug 21, 2026Locations: 4
Eligibility criteria
Adults subjects [+3]
History of cancer, with the exception of the following cancers with documentatio... [+3]